| Trial Identifier: | D3610C00001 |
| Sponsor: | AstraZeneca |
| Start Date: | December 2010 |
| Primary Completion Date: | April 2019 |
| Study Completion Date: | December 2024 |
| Condition: | Breast Cancer; Cancer - Other; Endometriosis; Ovarian Cancer; Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Danish Translation | |
| Spanish Translation | |
| French Translation | |
| Italian Translation | |
| Japanese Translation | |
| Dutch Translation |
| Country | Location |
|---|---|
| CA, AB | Edmonton, AB, CA, T6G 1Z2 |
| CA, BC | Vancouver, BC, CA, V5Z 4E6 |
| CA, ON | Toronto, ON, CA, M5G 2M9 |
| CA, QC | Montreal, QC, CA, H4A 3T2 |
| DK | København Ø, DK, 2100 |
| ES | Madrid, ES, 28041 |
| ES | Madrid, ES, 08035 |
| ES | Valencia, ES, 46010 |
| FR | PARIS CEDEX 5, FR, 75248 |
| FR | Pierre Benite CEDEX, FR, 69310 |
| FR | Villejuif, FR, 94805 |
| GB | Manchester, GB, M20 4BX |
| GB | Sutton, GB, SM2 5PT |
| IT | Milan, IT, 20141 |
| IT | Napoli, IT, 80131 |
| IT | Prato, IT, 59100 |
| JP | Chuo-ku, JP, 104-0045 |
| JP | Kashiwa, JP, 277-8577 |
| JP | Koto-ku, JP, 135-8550 |
| JP | Sapporo-shi, JP, 060-8638 |
| NL | Amsterdam, NL, 1066 CX |
| SG | Singapore, SG, 119228 |
| US, CA | Los Angeles, CA, US, 90089 |
| US, CA | Stanford, CA, US, 94304 |
| US, CA | West Hollywood, CA, US, 90048 |
| US, CO | Aurora, CO, US, 80045 |
| US, MA | Boston, MA, US, 02215 |
| US, NY | New York, NY, US, 10022 |
| US, OK | Oklahoma City, OK, US, 73104 |
| US, OR | Portland, OR, US, 97239 |
| US, SC | Charleston, SC, US, 29425 |
| US, TN | Nashville, TN, US, 37203 |
| US, TN | Nashville, TN, US, 37204 |
| US, TX | Houston, TX, US, 77030 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company